| 1. |
?International League Against Epilepsy. ILAE commission report.The epidemiology of the epilepsies:future directions. Epilepsia,1997, 38(5):614-618.
|
| 2. |
Kazushi Miya, Yukitoshi Takahashi, Hisashi Mori. Anti-NMDAR autoimmune encephalitis. Brain Develop, 2014, 210(36):645-652.
|
| 3. |
Sarria-Estrada S, Toledo M, Lorenzo-Bosquet C, et al. Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis. Clin Radio, 2014, 69(10):795-803.
|
| 4. |
Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-antibody encephalitis:Clinical manifestations and response to immunotherapy. J Neuroimmunology, 2013, 265(21):75-81.
|
| 5. |
李翔, 陳向軍. 抗N甲基-D-天冬氨酸受體腦炎患者臨床特點分析. 中華神經科雜志, 2012, 45(5):307-311.
|
| 6. |
劉愛華, 宋璐. 15例邊緣性腦炎臨床分析. 神經疾病與精神衛生, 2012, 12(6):598-601.
|
| 7. |
Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry, 2004, 75(7):1135-1140.
|
| 8. |
Demaerel P, Van Dessel W, Van Paesschen W, et al. Autoimmunemediated encephalitis. Neuroradiology, 2011, 53(9):837-851.
|
| 9. |
Davis R, Dalmau J. Autoimmunity Seizures and Status Epilepsy. Epilepsia, 2013, 54(6):46-49.
|
| 10. |
Liimatainen S, Peltola M, Fallah M, et al. The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures. Eur J Neurol, 2009, 16(10):134-141.
|
| 11. |
Rudzinski LA, Pittock SJ, McKeon A, et al. Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis. Epilepsy Res, 2011, 95(10):255e62.
|
| 12. |
Drislane FW. Nonconvulsive status epilepticus in patients with cancer. Clin Neurol Neurosurg, 1994, 96(8):314-318.
|
| 13. |
Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry, 2004,75(12):1135-1140.
|
| 14. |
Suvi Liimatainen, Jukka Peltola, Aki Hietaharju, et al. Lack of antibodies to NMDAR or VGKC-complexin GAD and cardiolipin antibody-positive refractory epilepsy. Epilepsy Research, 2014, 108(19):592-596.
|
| 15. |
Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decar-boxylase antibodies:diagnostic clues for this association. Brain, 2008, 131(10):2553-2563.
|
| 16. |
Sarria-Estrada S, Toledo M, Lorenzo-Bosquet C, et al. Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis. Clil Radiol, 2014, 69(8):795-803.
|
| 17. |
Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci, 2010, 30(7):5866-5875.
|
| 18. |
Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology, 2011,77(13):179-189.
|
| 19. |
Sudarshini R, Shekeeb S, Mohammad FB, et al. Autoimmune encephalitis:Recent updates and emerging challenges. J Clin Neurosci, 2014, 21(10):722-730.
|
| 20. |
Day GS, High SM, Cot B, et al. Anti-NMDA-receptor encephalitis:case report and literature review of an underrecognized condition. J Gen Intern Med, 2011, 26(8):811-816.
|
| 21. |
Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis:an observational cohort study. Lancet Neurol, 2013(12):157-165.
|
| 22. |
Lim JA, Lee ST, Jung KH, et al. Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Korea:Clinical Features, Treatment, and Outcome. J Clin Neurol, 2014, 10(2):157-161.
|
| 23. |
Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol, 2009(66):11-18.
|
| 24. |
Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis:case series and analysis of the effects of antibodies. Lancet Neurol, 2008, 7(2):1091-1098.
|
| 25. |
劉磊,宋兆慧,郭晶. 國人45例抗N-甲基-D-天冬氨酸受體腦炎病例分析. 中華神經科雜志, 2014, 47(7):474-481.
|
| 26. |
Daniela Di Capua, Sara García-Ptacek, Maria Eugenia García-García, et al. Extreme delta brush in a patient with anti-NMDAR encephalitis. Epileptic Disord, 2013, 15 (4):461-464.
|
| 27. |
Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels:a case series. Lancet Neurol, 2010(9):776-785.
|
| 28. |
Brown J.William L, Peter J. Martin,John W. Thorpe et al. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. J Neuroimmunology, 2014(271):66-68.
|
| 29. |
Kotsenas AL, Watson RE, Pittock RJ, et al. MRI Findings in Autoimmune Voltage-Gated Potassium Channel Complex Encephalitis with Seizures:One Potential Etiology for Mesial Temporal Sclerosis. AJNR Am J Neuroradiol, 2014(35):84-89.
|
| 30. |
Bettler B, Kaupmann K, Mosbacher J, et al. Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev, 2004(84):835-867.
|
| 31. |
Gambardella A, Manna I, Labate A, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology, 2003(60):560-563.
|
| 32. |
Eric Lancaster, Meizan Lai, Xiaoyu Peng, et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures:case series and characterisation of the antigen. Lancet Neurol, 2010(9):67-76.
|
| 33. |
Carvajal-Gonzalez A, Isabel Leite, Patrick Waters, et al. Glycine receptor antibodies in PERM and related syndromes:characteristics, clinical features and outcomes. Brain, 2014(137):2178-2192.
|
| 34. |
Lancaster E, Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology, 2011(11):1698-1701.
|
